The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
暂无分享,去创建一个
[1] K. Ghafarzadegan,et al. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features. , 2007, Archives of Iranian medicine.
[2] C. Vagianos,et al. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome. , 2007, In vivo.
[3] E. Maltezos,et al. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage. , 2006, The Journal of surgical research.
[4] Su-zhan Zhang,et al. Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma , 2005, Journal of Zhejiang University. Science. B.
[5] T. Vahlberg,et al. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. , 2005, World journal of gastroenterology.
[6] R. Broll,et al. Colorectal carcinomas with high MIB‐1 labelling indices but low pKi67 mRNA levels correlate with better prognostic outcome , 2003, Histopathology.
[7] A. Vecchione,et al. Prognostic impact of CD31 antigen expression in anal canal carcinoma. , 2001, Hepato-gastroenterology.
[8] A. Vecchione,et al. Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma. , 2000, Journal of experimental & clinical cancer research : CR.
[9] M. Banerjee,et al. Immunohistochemical Expression of bcl-2 and p53 Oncoproteins: Correlation with Ki67 Proliferation Index and Prognostic Histopathologic Parameters in Colorectal Neoplasia , 2000, Applied immunohistochemistry & molecular morphology : AIMM.
[10] S. Arii,et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma , 2000, Cancer.